Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Eye Drug Trial Marks Milestone For Southampton's Groundbreaking Research Centre, UK
Eye experts based at Southampton General Hospital are trialling a drug that could repair vision without the need for surgery.
generic viagra online
Going To Work When Sick May Lead To Future Absences
Employees who often go to work despite feeling sick have higher rates of future work absences due to illness, according to a study in the June Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
News of the day
IAS Conference Begins, Report Says Economic Crisis Forcing Africans Living With HIV/AIDS Off Life-Saving Medications
At a news conference opening the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention on Sunday in Cape Town, South Africa, Julio Montaner, president of the International AIDS Society, expressed disappointment that the "G8 ignored the HIV-AIDS issue at its annual summit this month," which was "just four years after pledging at the 2005 Gleneagles [G8] summit to fight for universal access to AIDS treatment by 2010," the Globe and Mail reports. "The silence of the G8 leaders is not just pathetic, it is criminal," Montaner said. The Global and Mail writes, "Cutting back on HIV-AIDS treatment programs during the recession will mean billions or even trillions of dollars in additional costs over the long term, especially because of growing scientific evidence that anti-retroviral medicine for AIDS patients can be crucial in preventing the transmission of the AIDS virus, Dr. Montaner said" (York, 7/20).
Medical Devices

Cost-Effectiveness Of HPV Vaccination In The Netherlands

Even under favorable assumptions, including lifelong protection against 70% of all cervical cancers and no side effects, vaccination against the human papillomavirus (HPV) is not cost-effective in the Netherlands, according to a study published online July 1 in the Journal of the National Cancer Institute. Researchers conducted the study because the cost effectiveness of HPV vaccination may be limited by the low number of cervical cancer cases and deaths in the region associated with the current Dutch cervical cancer screening program. In the study, Inge M.C.M. de Kok of the Department of Public Health at Erasmus MC, University Medical Center in Rotterdam, the Netherlands, and colleagues estimated the costs and effects of adding HPV vaccination to the current program (screening only) using a microsimulation screening analysis model. They found that adding HPV vaccination was not cost-effective, even under favorable assumptions. "To become cost-effective, the vaccine price would have to be decreased considerably, depending on the effectiveness of the vaccine," the authors write. Steve Graff Journal of the National Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009